Facility fees have become a controversial component of the reimbursement structure for ASCs as some advocates say they disincentivize patients from utilizing lower cost settings for surgical ...
Neuronoff, Inc., a clinical-stage neuromodulation company, today announced successful chronic large animal demonstration of its IPG-compatible Injectrode® platform, in which a single remotely ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results